Cargando…

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats

SIMPLE SUMMARY: Colon cancer is a major health problem, and its occurrence is rising particularly among young adults. Preventing this cancer is urgently needed. Earlier studies in animal models as well as on human have shown promising preventive effect of agents like Sulindac and DFMO. Unfortunately...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madka, Venkateshwar, Patlolla, Jagan M. R., Venkatachalam, Karthikkumar, Zhang, Yuting, Pathuri, Gopal, Stratton, Nicole, Lightfoot, Stanley, Janakiram, Naveena B., Mohammed, Altaf, Rao, Chinthalapally V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417047/ https://www.ncbi.nlm.nih.gov/pubmed/37568816 http://dx.doi.org/10.3390/cancers15154001

Ejemplares similares

Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials
por: Yarla, Nagendra S., et al.
Publicado: (2020)

Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer
por: Mohammed, Altaf, et al.
Publicado: (2017)

Development of a dietary formulation of the SHetA2 chemoprevention drug for mice
por: Benbrook, Doris M., et al.
Publicado: (2017)

Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas
por: Zell, Jason A., et al.
Publicado: (2012)

Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas
por: Raj, K P, et al.
Publicado: (2013)

Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives
por: Mohammed, Altaf, et al.
Publicado: (2018)

Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics
por: CHENG, KA-WING, et al.
Publicado: (2013)

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma
por: Rao, Chinthalapally V., et al.
Publicado: (2015)

Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice
por: PATLOLLA, JAGAN M.R., et al.
Publicado: (2015)

Sulindac for stroke treatment: neuroprotective mechanism and therapy
por: Modi, Jigar Pravinchandra, et al.
Publicado: (2014)

Amine Containing Analogs of Sulindac for Cancer Prevention
por: Mathew, Bini, et al.
Publicado: (2018)

Oxazole and thiazole analogs of sulindac for cancer prevention
por: Mathew, Bini, et al.
Publicado: (2018)

Targeting IL-23 for the interception of obesity-associated colorectal cancer
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
por: Davis, Jennifer S., et al.
Publicado: (2020)

Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression
por: Mohammed, Altaf, et al.
Publicado: (2015)

Evaluation of (99m)Tc-Probestin SPECT As a Novel Technique for Noninvasive Imaging of Kidney Aminopeptidase N Expression
por: Pathuri, Gopal, et al.
Publicado: (2014)

Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras(G12V) mice
por: Kumar, Gaurav, et al.
Publicado: (2021)

Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress
por: Marchetti, Maria, et al.
Publicado: (2009)

Sulindac Prevents Esophageal Adenocarcinomas Induced by Gastroduodenal Reflux in Rats
por: Kim, Sung Wook, et al.
Publicado: (2007)

A Desmoid Tumor Responding to Systemic Therapy With Tamoxifen and Sulindac
por: Choudhury, Hasan, et al.
Publicado: (2023)

Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer
por: Janakiram, Naveena B., et al.
Publicado: (2016)

Sulindac metabolites inhibit epidermal growth factor receptor activation and expression
por: Pangburn, Heather A, et al.
Publicado: (2005)

Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
por: Ayyanathan, Kasirajan, et al.
Publicado: (2012)

Sulindac activates NF-κB signaling in colon cancer cells
por: Mladenova, Dessislava, et al.
Publicado: (2013)

Analysis of the Dissolution Mechanism of Drugs into Polymers: The Case of the PVP/Sulindac System
por: Latreche, Mansour, et al.
Publicado: (2023)

Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits
por: Verheul, H M W, et al.
Publicado: (1999)

Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice
por: Bi, Xiuli, et al.
Publicado: (2013)

Synergistic cytotoxic effect of sulindac and pyrrolidine dithiocarbamate against ovarian cancer cells
por: JAKUBOWSKA-MUĆKA, ANNA, et al.
Publicado: (2012)

Induction of Apoptosis by Sulindac in Azoxymethane‐induced Possible Colonic Premalignant Lesions in Rats
por: Kuno, Toshiya, et al.
Publicado: (2002)

Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers
por: Tang, Yong-Jun, et al.
Publicado: (2017)

Radioprotective Potential of Sulindac Sulfide to Prevent DNA Damage Due to Ionizing Radiation
por: Torabizadeh, Seyedeh Atekeh, et al.
Publicado: (2019)

The effect of sulindac on redox homeostasis and apoptosis-related proteins in melanotic and amelanotic cells
por: Miliński, Maciej, et al.
Publicado: (2023)

Effect of Sulindac Sulfide on Metallohydrolases in the Human Colon Cancer Cell Line HT-29
por: Guillen-Ahlers, Hector, et al.
Publicado: (2011)

Sulindac Derivatives That Activate the Peroxisome Proliferator-activated Receptor γ but Lack Cyclooxygenase Inhibition
por: Felts, Andrew S., et al.
Publicado: (2008)

Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer
por: CHENG, KA WING, et al.
Publicado: (2012)

The efficacy and safety of sulindac for colorectal polyps: A protocol for systematic review and meta-analysis
por: Long, Qing, et al.
Publicado: (2020)

Modification of the Release of Poorly Soluble Sulindac with the APTES-Modified SBA-15 Mesoporous Silica
por: Dadej, Adrianna, et al.
Publicado: (2021)

Sulindac selectively induces autophagic apoptosis of GABAergic neurons and alters motor behaviour in zebrafish
por: Sun, Wenwei, et al.
Publicado: (2023)

Cyclooxygenase-1-Selective Inhibitors Based on the (E)-2′-Des-methyl-sulindac Sulfide Scaffold
por: Liedtke, Andy J., et al.
Publicado: (2012)

Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate
por: MURRAY, ONIKA T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sajes6ecpc072k1k9af6939oq1